chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021 at 11:31 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 18-Nov-2021 at 11:31 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Nov-2021 at 11:31 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment medication were not reported.
Father of his friend got the vaccine (not sure if it is Moderna or Pfizer) got rash and hives; Father of his friend got the vaccine (not sure if it is Moderna or Pfizer) got rash and hives; so much pain; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (COVID-19 VACCINE MANUFACTURER UNKNOWN, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date, as a dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced father of his friend got the vaccine (not sure if it is moderna or pfizer) got rash and hives. Caller was planning to get the Pfizer COVID 19 vaccine. He wants to know if there will be any issues or interaction if he was taking any nutritional products and supplements. He saw in the news that some people who have received the vaccine had violent reactions and not sure if it was due to taking lots of nutritional products. Caller wants to know if there was any information about nutritional products that could affect the vaccine. Father of his friend got the vaccine (not sure if it is Moderna or Pfizer) got rash and hives, so much pain, need to inject morphine for 3 weeks. Caller heard on the news about people who had violent reactions from the vaccine, father of his friend had rash and hives. He mentioned that he will ask his friend if it was Moderna or Pfizer that his father got. Caller refused to provide other contact information and personal details. Father of his friend got the vaccine (not sure if it is Moderna or Pfizer) got rash and hives, so much pain, need to inject morphine for 3 weeks. Caller mentioned that the fact sheet for recipients and caregivers for Pfizer COVID-19 vaccine does not contain any information about interaction between nutritional products/herbs and vaccine. He also mentioned that it should be somehow discussed in the fact sheet about what nutritional products could or could not be appropriate before taking the vaccine. It was reported that product quality compliant was reported. The outcome of the events was reported as unknown.  Information about lot/batch number has been requested.
Ringing in the ears,the  left first followed by the right several months later, approxiamtely 30 days after receiving the booster shot.
Moderna COVID-19 Vaccine - Moderate tenderness, vaccination area slightly hardened but not red  April 8 (VAX date) - 10. No symptoms April 11-13. Arm felt tender again at bedtime April 14. Vaguely tender to touch April 15 daytime. Bedtime April 15 - vaccinated area became itchy and slightly reddened, mildly tender to touch. Today (April 16) Redness continues, itchiness is constant. I am not alarmed, but this change is unexpected and seems unusual.
Site: Swelling at Injection Site-Medium, Systemic: Abdominal Pain-Mild, Systemic: Body Aches Generalized-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: Headache-Mild, Systemic: Joint Pain-Mild, Systemic: Nausea-Medium, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Weakness-Mild
A report was received from a female consumer (age not reported) in the USA on 08/30/2004.  Details regarding her medical history or concomitant medications were not provided. On 12/01/03, the vaccinee received an IM injection of an influenza vaccine (manufacturer unknown). Within one week, the vaccinee began to experience rib pain, back pain and swollen and painful feet. In 01/04, the vaccinee was seen by a primary care physician who indicated that she had serum sickness. There was a rash at the top of her foot and it was painful to walk. At the time of this report, the swelling and pain in her feet persists and she also has swollen hands. The back and rib pain have now resolved. Further information will be sought.
Symptoms: edema, redness, warmth, and pain surrounding vaccine site increasing in intensity. Symptoms first noticed by patient approximately 18 hours post injection. Warm compresses, ice packs, and ibuprofen were initial treatment but were not helpful as symptoms continued to intensify. Patient was seen by PCP on 4th day of symptoms and diagnosed with cellulitis and given antibiotic treatment. Treatment is currently ongoing
positive COVID test on 8/19/21; presented to ED with generalized malaise, rhinorrhea, fever; acute hypoxic respiratory failure; acute renal failure superimposed on CKD stage 4
pt received 2nd dose of Moderna at 21 days instead of the scheduled 28 day time frame.
Patient received vaccine without age verification.Patient was 14 years and 10 months. After 50 hours, patient has sore ULE, but no other symptoms.
Information has been received from a licensed practical nurse (LPN) concerning a 20-year-old female with no allergies and a history of anemia who on 02-DEC-1987 and 01-AUG-1993 was vaccinated subcutaneously with a first and second dose of MMR II. The second dose was administered in the left arm and the lot # was 606866/0544W. On 22-JUL-2005 and 12-AUG-2005 the patient had IgG antibody titers that were negative for rubeola. Unspecified medical attention was sought. ON 22-AUG-2005, the patient received a third vaccination of MMR II 0.5 ml given subcutaneously in the right arm (lot # 647106/0793N). There was no illness at the time of vaccination. The LPN noted that concomitant medication at the time of the third vaccination included TRINESSA. Another IgG test was done on 25-AUG-2006 and results indicated that the patient was negative for rubeola and positive for mumps and rubella. Unspecified medical attention was sought. At the time of this report it was noted that the patient had "not recovered, not immune to rubeola." No product quality complaint was involved. The patient's vaccination records were reported as follows: diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unspecified) given on 08-AUG-1986, 07-OCT-1986, 09-DEC-1986, 03-JUN-1991 and a booster dose given on 02-JUL-2003 (0.5 ml dose given IM in the left arm lot # U0840AA); poliovirus vaccine inactivated (unspecified) given on 08-AUG-1986, 07-OCT-1986 and 02-DEC-1987; Hib conj vaccine (OMPC) (manufacturer unspecified) given on 10-JUN-1988; and hepatitis B virus vaccine rHBsAg (manufacturer unspecified) given on 27-MAR-1997, 28-MAY-1997 and 29-JUL-1998. Additional information is not expected.
Approximatley 10 minutes after the vaccination was given, the patient stated he felt a little lightheaded, dizzy, a little sweaty and said his vision was blurry for a few minutes.  We gave him smelling salts & some water; he sat down for abouit 20 more minutes until he felt better.
Rash on abdomen; This is a spontaneous report from a contactable other healthcare professional (patient). A 43-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ELO-140), via an unspecified route of administration on left arm at 10:15 on 03Jan2021 at single dose for COVID-19 immunization. Medical history reported as none. The patient's concomitant medications were not reported. The patient experienced rash on abdomen on 05Jan2021 at 08:00. The patient did not receive any treatment for event. The outcome of event was not recovered. The patient was not diagnosed COVID prior vaccination; The patient had not COVID tested post vaccination.
Progressively following vaccine on 3/4/21 became more fatigued until taken to hospital on 3/13/21.  Found to have lesions on liver and in lungs on scans.  Told to follow up with Oncologist on 3/16 but instead had to go to ED due to worsened fatigue and confusion. Liver enzymes noted to be very elevated on admission and progressively deteriorated in to liver failure and subsequent kidney failure over 3 day hospitalization. Unable to biopsy lesions due to risk of bleeding. Discharged to hospice facility on 3/19/21 and died 3/20/21 early AM.
On July 30, I was so fatigued I slept 19 of 24 hours. The next day I slept 14 hours. I had severe brain fog and was exhausted. My arm was also so sore it hurt to move it.   Starting on July 2nd, three days after my second Moderna shot, I woke up in the early AM hours with my heart beating strongly and at a very high rate. I had a pulsing in my face around my eyes that was also very distracting and my entire body felt like it was vibrating. I took my heart rate and it was 110 beat/minute. I am a very fit individual, I am not overweight, I exercise regularly and eat healthy. I do not abuse drugs or alcohol and get 9 hours of rest per night.  I was very alarmed and went to my local Urgent Med at 8AM.  My heart rate did decrease to 80 beats/minute but it was still very strong - I could FEEL my heart beating.  The doctor sent me home to self monitor.    A few days later the lymph notes on my right side, where I had the shot, became extremely enlarged. I took Ibuprofen. My throat was also sore. These symptoms lasted three days.   Of the course of the next 5 weeks my heart continued to pound no matter what I was doing and the pulsing in my face also continued to the point where these symptoms would wake me up. I also had a lot of brain fog and had trouble concentrating.   I am writing this now on August 11 and this is the first week I feel normal.  I will NOT be getting a booster shot. This was one of the scariest health developments I have ever had and this shot did something to my heart and entire system that I do not want to ever experience again. I am going to go to the doctor to have an EKG to ensure that my heart is functioning normally.
right shoulder to elbow extreme pain, weakness of right arm with holding cup, achy, headache worsening x 10 days
Big red upper arm - site area. Swelling of right side of pt face and lower wrist area. Bruising around wrist.
became very sore under my armpit and now it is very swollen and sore; became very sore under my armpit and now it is very swollen and sore; This is a spontaneous report from a contactable other health professional (patient). A 57-year-old non-pregnant female patient received second dose of BNT162B2 (Solution for injection, Batch/Lot number: 9262) via an unspecified route of administration in the left arm on 31Jan2021 at 09:15 (at the age of 57-years-old) as a single dose for Covid-19 immunisation. Medical history included diabetes. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included metformin hydrochloride/sitagliptin phosphate monohydrate (JANUMET) and rosuvastatin. The patient previously received first dose of BNT162B2 in left arm on 10Jan2021 at 01:15 PM for Covid-19 immunisation. The patient stated two days after 2nd vaccine, 02Feb2021, she became very sore under her armpit & now it was very swollen and sore. Seriousness criteria was considered as non-serious. No treatment was received for the adverse events. The outcome of the events was not recovered.
Patient requested and received  Pfizer booster but data entered in system states patient received Moderna Booster. Followed up with paper trail and Nurse  administrator all confirmed Pfizer booster was given. System has been updated.
Client was to young to receive the Moderna vaccine and was given the second dose on 05/01/2021. The first dose was given on 04/3/21 lot number 018B21A). Per the Chief Medical Director the second dose has to be given to complete the series. Following the guidelines of Administration and error documentation and deviation and error (recommendations as off label use)
he got sick a week after receiving the vaccine; he had COVID; he has not received his 2nd dose of the vaccine yet; he was underage at the time of his 1st dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-May-2021 and was forwarded to Moderna on 04-May-2021.    This spontaneous case was reported by a physician and describes the occurrence of ILLNESS (he got sick a week after receiving the vaccine), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (he was underage at the time of his 1st dose), COVID-19 (he had COVID) and PRODUCT DOSE OMISSION ISSUE (he has not received his 2nd dose of the vaccine yet) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (he was underage at the time of his 1st dose) and PRODUCT DOSE OMISSION ISSUE (he has not received his 2nd dose of the vaccine yet). On an unknown date, the patient experienced ILLNESS (he got sick a week after receiving the vaccine) and COVID-19 (he had COVID). At the time of the report, ILLNESS (he got sick a week after receiving the vaccine), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (he was underage at the time of his 1st dose), COVID-19 (he had COVID) and PRODUCT DOSE OMISSION ISSUE (he has not received his 2nd dose of the vaccine yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
10feb2021 - 1st dose -  Friday , I was the  numb in head in face, back of the head and in fingers and toes and feet. Saw the doctor on Friday. After the 2nd shot. The arm didn't and nothing changed.
1)  red, swollen, painful left arm for 3 days; 2)  vertigo and lightheadedness for 14 days so far, ongoing.
3rd visit to ACC secondary to persistently high fevers and diffuse skin rash, swelling over the past 5 days. Patient states symptoms began the day after receiving her 1st covid vaccine. Has been taking steroids, benadryl, and pepcid 2 days prior. Returned to ACC yesterday with fever up to 104.5 and then broke out into a diffuse rash. had swelling around the eyes.
PFIZER COVID VACCINE #3 GIVE 9/14/21, LOT #FF2589; pt had a positive COVID test on 1/21/22 and was seen in the ED, dc'd to home; 1/25/22 back to ED with increasing SOB, nausea, productive cough; admitted; COVID pneumonia; given dexamethasone, remdesivir, baricitinib; O2 supplementation - NRB; DNR/DNI; transitioned to comfort care and she expired in the hospital
Physician diagnosed shingles-red eruptions in right chest, lateral area with fever, pain and itching of vesicles.
This case was reported by a physician via call center representative and described the occurrence of injection site induration in a 62-year-old female patient who received Shingrix for prophylaxis. On 28th August 2018, the patient received Shingrix. In August 2018, less than a week after receiving Shingrix, the patient experienced injection site induration, injection site swelling, headache and general body pain. On an unknown date, the outcome of the injection site induration, injection site swelling, headache and general body pain were unknown. It was unknown if the reporter considered the injection site induration, injection site swelling, headache and general body pain to be related to Shingrix. Additional details were provided as follows: A patient experienced an indurated area at the injection site after receiving Shingrix. Reporting physician was in a rush at time of call, so no more information was obtained. swelling and headache symptoms were shared by medical information (MI) colleague after physician was escalated to her.
This spontaneous report as received from a nurse refers to a 61 year old patient of unknown gender. No medical history provided. On 17-APR- 2013 the patient was vaccinated with ZOSTAVAX (dosing, frequency, indication; lot # H018510, exp 15-JAN-2014). The vaccine had been improperly stored at minus 5C since 14-FEB-2013. Unknown whether the patient had been using any concomitant medications. No adverse event was reported. Additional information has been requested.
Patient was standing/leaning on a chair when they lost consciousness and fell from standing onto the floor. (syncope) Patient regained consciousness within a few minutes. Patient recovered after having some water within 15 or so minutes.
She was given standard 12 month vaccinations on 10/22/2013: Varicella, Hep A, Hib, and MMR. On 10/24 she developed urticaria with red, slightly raised macular rash, mostly to skin folds, abdomen and extremities c/w urticaria. (NOT a measles like rash). Baby is otherwise feeling entirely well. Developed rash in her inner thighs. The rash then spread up her abdomen to her chest. Then extends to the axilla bilaterally. She has a history of eczema but no prior adverse reaction to vaccines before. She was seen in clinic on 10/24 and rash had resolved by the next day.
developed left side facial numbness and weakness, head pressure, neck pain near base of skull, chills, and aches
COUGH FELT EXHAUSTED SLEPT FROM 4:00PM TILL 8:00AM {STARTED SATURDAY - LASTED TILL MONDAY EVENING NO APPETITE
Mom reported/sent in picture of patients right arm- Circular bruise/rash noted still 3/14/23.   Mom reports after vaccines patient gets redness that looks like a sunburn. This became itchy and hot as well. Redness grew in diameter.
Patient was vaccinated on 02MAR21 @ 0900.  She presented to our onsite nurse on 10MAR21 with injection site pain, swelling and redness.  She was advised to take Benadryl when she gets home and to follow-up as needed.
pt screamed (unusual, high-pitched cry) for five to six hrs p/receiving immun; no treatment required; pt recovered completely w/no adverse effect;
A nurse reported the occurrence of injection site cellulitis in a 5-year-old male who was vaccinated with dephtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  The vaccine provider submitted this report directly to VAERS.  The subject had no relevant medical history, concurrent conditions, or concurrent medications.  The subject experienced no adverse events following previous immunizations.  On 01/31/2003, the subject received his fifth injection of Infanrix (lot DTPA582b2).  On the same date, he received injections of inactivated poliomyelitis virus vaccine (IPOL) and measles, mumps and rubella virus vaccine (MMR II).  On 02/03/2003, three days post-immunization, the subject developed a "huge red rash"  that was the "size of a baseball" at the Infanrix injection site, and swelling of the entire thigh to the knee.  He was seen by the physician, who made a diagnosis of injection site cellulitis and prescribed unspecified antibiotics.  The reporting nurse considered the injection site cellulitis to be related to Infanrix administration.  The injection site cellulitis resolved by 02/13/2003.  Comment:  This is one of four subjects from this facility, out of more than 30 children immunized, who experienced adverse events following receipt of two lots of Infanrix.  Please see reports A0397368A, A0399836A, and A0399837A.
soreness inject site, swelling, low grade fever reported to ER-2 day wound ck 26JAN95;
A rash on my upper left arm surrounding the injection shot site where a small raised area in a circle surrounded the injection location. This occurred 3.5 days after receiving the injection
Chills and shaking consistent with flu-like symptoms began about 12 hours following vaccination.  The next morning, I had a headache and vomited about 5 times.  Over the next several hours, I began to feel better and by that evening, was feeling pretty much normal, except for some lingering fatigue.
A non-serious spontaneous report of expired FLUMIST administered was received from a health professional concerning a 14-year-old female. Neither medical history nor concomitant medication was reported for this patient. The FLUMIST expired on 29-Nov-2010. On 14-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information received on 09-Mar-2011 and incorporated into case: no late occurring adverse events.
Several bouts of dizziness within 2 hours gradually be came less frequent over the next 24 hours.
Initial unsolicited report received from other non-healthcare professional on 18-JAN-2017. This case is linked with 2017SA012171 (same reporter). This case involves 05 patients (age and gender reported (most are elderly) as male or female) who were vaccinated with a dose of FLUZONE HD intramuscularly and FLUZONE QIV (Batch number, expiry date site and route of administration were not reported for both vaccine) on an unspecified date. Patients did not have any illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions include rheumatological disorders. It was reported that reporter was unsure whether patient received any other vaccinations within 4 weeks of vaccinations. On an unspecified date, following vaccination, patients were ill with flu like symptoms in last two week, hospitalized with pneumonia and were very ill. On an unspecified date patient had emergency room or doctors visit. The reporter considered these events as life threatening. On an unspecified date Flu testing by laboratory and also throat Swab all Negative. Corrective treatment was not reported. Outcome of events was unknown. List of documents held by sender: none. Sender's Comments: It was reported that about 5 patients who received either INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE or INFLUENZA QUADRIVAL A-B VACCINE and experienced ill with flu like symptoms, and hospitalized with Pneumonia and are very ill. Time to onset is unknown. This case is very poorly documented to assess the role of the vaccine. However, investigation results ruling out a concurrent condition and other etiologies would be helpful to further assess this case.
Patient is a type 1 diabetic that went into diabetic ketoacidosis. Patient has never gone into DKA and is requiring hospitalization because of this. Patient possibly had an NSTEMI as well.
Reported tingling in face and "inside" while indicating her chest. Symptoms remained steady for 30 minutes and vital signs were stable.